AAAAAA
Results:
1-15
|
Results: 15
Authors:
GRIMALDI C
BLEIBERG H
GAY F
MESSNER M
ROUGIER P
KOK TC
CIRERA L
CERVANTES A
DEGREVE J
PAILLOT B
BUSET M
NITTI D
SAHMOUD T
DUEZ N
WILS J
Citation: C. Grimaldi et al., EVALUATION OF ANTIANDROGEN THERAPY IN UNRESECTABLE HEPATOCELLULAR-CARCINOMA - RESULTS OF A EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENTOF CANCER MULTICENTRIC DOUBLE-BLIND TRIAL, Journal of clinical oncology, 16(2), 1998, pp. 411-417
Authors:
KOK TC
NOOTER K
TJONGAHUNG SP
SMITS HL
TERSCHEGGET J
Citation: Tc. Kok et al., NO EVIDENCE OF KNOWN TYPES OF HUMAN-PAPILLOMAVIRUS IN SQUAMOUS-CELL CANCER OF THE ESOPHAGUS IN A LOW-RISK AREA, European journal of cancer, 33(11), 1997, pp. 1865-1868
Authors:
KOK TC
VANDERGAAST A
SPLINTER TAW
Citation: Tc. Kok et al., 13-CIS-RETINOIC ACID AND ALPHA-INTERFERON IN ADVANCED SQUAMOUS-CELL CANCER OF THE ESOPHAGUS, European journal of cancer, 33(1), 1997, pp. 165-166
Authors:
KOK TC
Citation: Tc. Kok, CHEMOTHERAPY IN ESOPHAGEAL CANCER, Cancer treatment reviews, 23(2), 1997, pp. 65-85
Authors:
VANDERGAAST A
KOK TC
VOS R
KERKHOFS L
SPLINTER TAW
Citation: A. Vandergaast et al., A PHASE-I DOSE-FINDING STUDY OF A BIWEEKLY SCHEDULE OF A FIXED-DOSE OF CISPLATIN WITH INCREASING DOSES OF PACLITAXEL IN PATIENTS WITH ADVANCED ESOPHAGEAL CANCER, Seminars in oncology, 24(6), 1997, pp. 82-85
Authors:
KOK TC
VANDERGAAST A
SPLINTER TAW
Citation: Tc. Kok et al., 5-FLUOROURACIL AND FOLINIC ACID IN ADVANCED ADENOCARCINOMA OF THE ESOPHAGUS OR ESOPHAGOGASTRIC JUNCTION AREA, Annals of oncology, 7(5), 1996, pp. 533-534
Authors:
KOK TC
TILANUS HW
Citation: Tc. Kok et Hw. Tilanus, NEOADJUVANT TREATMENT IN ESOPHAGEAL CANCER - THE NEEDS FOR FUTURE TRIALS, European journal of surgical oncology, 22(4), 1996, pp. 323-325
Authors:
KOK TC
VANDERGAAST A
DEES J
EYKENBOOM WMH
VANOVERHAGEN H
STOTER G
TILANUS HW
SPLINTER TAW
Citation: Tc. Kok et al., CISPLATIN AND ETOPOSIDE IN ESOPHAGEAL CANCER - A PHASE-II STUDY, British Journal of Cancer, 74(6), 1996, pp. 980-984
Authors:
VANDERGAAST A
KOK TC
KHO GS
BLIJENBERG BG
SPLINTER TAW
Citation: A. Vandergaast et al., DISEASE MONITORING BY THE TUMOR-MARKERS CYFRA-21.1 AND TPA IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER, European journal of cancer, 31A(11), 1995, pp. 1790-1793
Authors:
SIERSEMA PD
DEES J
TILANUS HW
KOK TC
HORDIJK ML
VANBLANKENSTEIN M
Citation: Pd. Siersema et al., EARLY DETECTION AND TREATMENT OF ESOPHAGEAL AND GASTRIC-CANCER, Netherlands journal of medicine, 47(2), 1995, pp. 76-86
Authors:
VANDERGAAST A
SCHOENMAKERS CHH
KOK TC
BLIJENBERG BG
HOP WCJ
SPLINTER TAW
Citation: A. Vandergaast et al., PROGNOSTIC-SIGNIFICANCE OF TISSUE POLYPEPTIDE-SPECIFIC ANTIGEN (TPS) IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, European journal of cancer, 30A(12), 1994, pp. 1783-1786
Authors:
VANDERGAAST A
BONTENBAL M
PLANTING AST
KOK TC
SPLINTER TAW
Citation: A. Vandergaast et al., PHASE-II STUDY OF CARBOPLATIN AND ETOPOSIDE AS A FIRST-LINE REGIMEN IN PATIENTS WITH METASTATIC BREAST-CANCER, Annals of oncology, 5(9), 1994, pp. 858-860
Authors:
VANDERGAAST A
SCHOENMAKERS CHH
KOK TC
BLIJENBERG BG
CORNILLIE F
SPLINTER TAW
Citation: A. Vandergaast et al., EVALUATION OF A NEW TUMOR-MARKER IN PATIENTS WITH NON-SMALL-CELL LUNG-CANCER - CYFRA-21.1, British Journal of Cancer, 69(3), 1994, pp. 525-528
Authors:
HORDIJK ML
KOK TC
WILSON JHP
MULDER AH
Citation: Ml. Hordijk et al., ASSESSMENT OF RESPONSE OF ESOPHAGEAL-CARCINOMA TO INDUCTION CHEMOTHERAPY, Endoscopy, 25(9), 1993, pp. 592-596
Authors:
VANOVERHAGEN H
BERGER MY
MEIJERS H
TILANUS HW
KOK TC
STIJNEN T
LAMERIS JS
Citation: H. Vanoverhagen et al., INFLUENCE OF RADIOLOGICALLY AND CYTOLOGICALLY ASSESSED DISTANT METASTASES ON THE SURVIVAL OF PATIENTS WITH ESOPHAGEAL AND GASTROESOPHAGEAL JUNCTION CARCINOMA, Cancer, 72(1), 1993, pp. 25-31
Risultati:
1-15
|